StonvexLoading…
StonvexStonvexStonvexCore line items from ABAT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $13.51M | $5.70M | $937.59K | $4.29M |
Operating Income | $-54.41M | $-20.01M | $-10.13M | $-42.02M |
Net Income | $-53.42M | $-9.28M | $-10.30M | $-46.76M |
EPS (Diluted) | $-0.43 | $-0.16 | $-0.09 | $-0.58 |
Total Assets | $119.43M | $123.34M | $101.47M | $84.46M |
Total Liabilities | $6.67M | $4.36M | $5.47M | $13.86M |
Cash & Equivalents | $37.70M | $47.90M | $30.90M | $7.47M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 132.27M | 131.03M | 120.31M | 97.40M |